Zipnosis snags $3M in new funding round

Zipnosis, a virtual care software company, raised $3 million in Series B funding.

Advertisement

The company plans on using the funds to support continued organizational growth in several areas, including sales, product enhancements and customer support.

In the past two years, the company has expanded its platform and services, including the launch of new patient outreach functionality. The company also partnered with the American Academy of Family Physicians.

“In this industry, you hear about huge amounts of cash being splashed around. Zipnosis didn’t require a massive infusion of investment to achieve our growth objectives. It was more important for us to take precisely what we needed to move to the next level — no more and no less,” said Zipnosis CEO Jon Pearce.

More articles on telehealth:
FCC advances work on $100M telehealth pilot program
Consumer Technology Association names 1st VP of digital health: 3 things to know
Which IT trend is most promising? 29% of provider execs say telemedicine

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.